Over the years, we’ve pointed out when federal agencies opt to ignore the federal illegality of cannabis. It happens more often than you might think depending on the topic (see, for example, the NLRB). One agency, though, that has surprisingly never lifted a finger against state-legal cannabis–though it is taking a closer look at CBD–is […]

The post NIST and FDA May Be the Cannabis Quality Assurance Heroes We Need appeared first on Harris Bricken.

  We introduced our readership to TCPA claims in this post last month, and it looks like our prediction was right: this week, Curaleaf became the latest defendant in a long line of TCPA class action complaints filed against cannabis companies this year. The Complaint is brought by a Katherine Brooks in the Southern District […]

The post Curaleaf Meets the TCPA appeared first on Harris Bricken.